| 000 | 01788 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516111450.0 | ||
| 264 | 0 | _c20130610 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gutjnl-2012-303285 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRungoe, Christine | |
| 245 | 0 | 0 |
_aRisk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. _h[electronic resource] |
| 260 |
_bGut _cMay 2013 |
||
| 300 |
_a689-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAtherosclerosis _xepidemiology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDenmark _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMercaptopurine _xtherapeutic use |
| 650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xepidemiology |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBasit, Saima | |
| 700 | 1 | _aRanthe, Mattis Flyvholm | |
| 700 | 1 | _aWohlfahrt, Jan | |
| 700 | 1 | _aLangholz, Ebbe | |
| 700 | 1 | _aJess, Tine | |
| 773 | 0 |
_tGut _gvol. 62 _gno. 5 _gp. 689-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gutjnl-2012-303285 _zAvailable from publisher's website |
| 999 |
_c22089532 _d22089532 |
||